[3] The FDA has separately warned about adverse events tied to dosing mistakes with compounded GLP-1s, including patients receiving 5 to 20 times the intended dose
Other studies demonstrated that SIRT1 activation by the GLP-1 agonist exendin-4 treatment protects mice under a high fat diet condition (Lee et al., 2012) and attenuates palmitate-induced ER stress and mitochondrial dysfunction (Lee et al., 2014)
Wegovy (for weight management) Liraglutide - Victoza (for type 2 diabetes)
It is one of the most affordable prescription weight loss medications available
Its glucagon receptor activation , though historically associated with hyperglycemia, is balanced by GLP-1 and GIP action , creating a net glycemic improvement
The Growing Epidemic The World Health Organization (WHO) defines overweight for Asians as a Body Mass Index (BMI) of 23 kg/m or higher and obesity as 27.5 kg/m or higherthresholds lower than global standards due to the higher body fat percentage in Asians at lower BMIs